Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Expert Opinion on Pharmacotherapy|July 1, 2010
Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancerAthanasios Kotsakis, Vassilis Georgoulias
Expert Review of Molecular Diagnostics|December 30, 2016
Classifying circulating tumor cells to monitor cancer progressionPanagiota Economopoulou, Vassilis Georgoulias, Athanasios Kotsakis
Expert Opinion on Emerging Drugs|May 4, 2016
Emerging agents for the prevention of treatment induced neutropenia in adult cancer patientsAlexios Matikas, Vassilis Georgoulias, Athanasios Kotsakis
Translational Lung Cancer Research|March 10, 2016
Small cell lung cancer (SCLC): no treatment advances in recent yearsFilippos Koinis, Athanasios Kotsakis, Vasileios Georgoulias
Expert Review of Respiratory Medicine|March 15, 2019
The role of immune checkpoint inhibitors in advanced non-small cell lung cancerNikolaos F Pistamaltzian, Vassilis Georgoulias, Athanasios Kotsakis
Cells|December 19, 2019
Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in CancerEleni-Kyriaki Vetsika, Aristeidis Koukos, Athanasios Kotsakis
Critical Reviews in Oncology/Hematology|January 23, 2017
Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entityAlexios Matikas, Dimitrios Mistriotis, Vasilios Georgoulias, et al.
Expert Opinion on Pharmacotherapy|June 17, 2015
Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumorsFilippos Koinis, George Nintos, Vassilis Georgoulias, et al.
Cancer Management and Research|June 18, 2015
Cancer therapy and cardiovascular risk: focus on bevacizumabPanagiota Economopoulou, Athanasios Kotsakis, Ioannis Kapiris, et al.
Pageof 13